Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2323)
All Articles published online
|
Oct 15, 2004 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El-Zayadi A, Selim O, Hamdy H, El-Tawil A, Badran HM, Attia M, Saeed A. Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World J Gastroenterol 2004; 10(20): 2963-2966 [PMID: 15378774 DOI: 10.3748/wjg.v10.i20.2963] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i20/2963.htm |
| Number | Citing Articles |
| 1 |
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim. Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome. The Korean Journal of Internal Medicine 2012; 27(1): 47 doi: 10.3904/kjim.2012.27.1.47
|
| 2 |
Gabriel Olaiya Omotoso, Bernard U Enaibe, Oluwole Busayo Akinola, R Eniola Kadir, Adelaja A Akinlolu, Adeoye Oyetunji Oyewopo, Solomon Toluwase Olawuyi, Joseph Oluwatope Adebayo, , Olanrewaju Samuel Apalowo, Adeyemi Victor Sofoluwe. Lipid Profile and Liver Histochemistry in Animal Models Exposed to Cigarette Smoke. Journal of Basic & Applied Sciences 2012; 8(1): 12 doi: 10.6000/1927-5129.2012.08.01.04
|
| 3 |
Ekram W. Abd El‐Wahab, Ashraf Mikheal, Fathallah Sidkey, Hanan Z. Shatat. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian Patients. Journal of Medical Virology 2015; 87(3): 428 doi: 10.1002/jmv.24092
|
| 4 |
|
| 5 |
Ramón Bataller. Time to ban smoking in patients with chronic liver diseases. Hepatology 2006; 44(6): 1394 doi: 10.1002/hep.21484
|
| 6 |
Niamh E Mangan, Ka Yee Fung. Type I interferons in regulation of mucosal immunity. Immunology & Cell Biology 2012; 90(5): 510 doi: 10.1038/icb.2012.13
|
| 7 |
Tuyyab Hassan, Corey Sievers, Kiran Anna. Hepatitis C Treatment Response in Patients with a Tobacco History: An Inner City Hospital Experience. American Journal of Gastroenterology 2010; 105: S95 doi: 10.14309/00000434-201010001-00254
|
| 8 |
Swati Joshi-Barve, Kiranmayi Amancherla, Madhuvanti Patil, Aruni Bhatnagar, Stephanie Mathews, Leila Gobejishvili, Matthew Cave, Craig McClain, Shirish Barve. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-α: relevance to hepatitis C. Free Radical Biology and Medicine 2009; 47(1): 47 doi: 10.1016/j.freeradbiomed.2009.03.021
|
| 9 |
Amy K. Silberbogen, Erin W. Ulloa, E. Amy Janke, DeAnna L. Mori. Psychosocial Issues and Mental Health Treatment Recommendations for Patients With Hepatitis C. Psychosomatics 2009; 50(2): 114 doi: 10.1176/appi.psy.50.2.114
|
| 10 |
Carol Reid, Mary Fenech, Lee Jones, Nasim Salehi. Nurse practitioner interventions for smokers with chronic hepatitis C. Journal of the American Association of Nurse Practitioners 2020; 32(5): 380 doi: 10.1097/JXX.0000000000000311
|
| 11 |
H. PATEL, E. J. HEATHCOTE. When to treat and the benefits of treating hepatitis C in patients with haemophilia. Haemophilia 2009; 15(1): 20 doi: 10.1111/j.1365-2516.2008.01917.x
|
| 12 |
|
| 13 |
José L. Alonso-Martínez, Francisco J. Anniccherico-Sánchez, Miren Urbieta-Echezarreta, Jose L. Garcia-Sanchotena, Fernando Olaz-Preciado. Hemodynamic effects of chronic smoking in liver cirrhosis: a role for adrenomedullin. European Journal of Gastroenterology & Hepatology 2010; 22(5): 513 doi: 10.1097/MEG.0b013e328335b2b2
|
| 14 |
Nathan Ford, Catherine Kirby, Kasha Singh, Edward J Mills, Graham Cooke, Adeeba Kamarulzaman, Philipp duCros. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bulletin of the World Health Organization 2012; 90(7): 540 doi: 10.2471/BLT.11.097147
|
| 15 |
Wei-Chun HuangFu, Jianghuai Liu, Ronald N. Harty, Serge Y. Fuchs. Cigarette smoking products suppress anti‐viral effects of Type I interferon via phosphorylation‐dependent downregulation of its receptor. FEBS Letters 2008; 582(21-22): 3206 doi: 10.1016/j.febslet.2008.08.013
|
| 16 |
Abdel-Rahman El-Zayadi. Heavy smoking and liver. World Journal of Gastroenterology 2006; 12(38): 6098-6101 doi: 10.3748/wjg.v12.i38.6098
|
| 17 |
Zhenni Lu, S. Islam, W. Liu. Smoking Products Suppress Type I IFN During SARS-Cov-2 Infection. E3S Web of Conferences 2021; 292: 03095 doi: 10.1051/e3sconf/202129203095
|
| 18 |
Jia Liu, Qinyu Yao, Xinya Xie, Qi Cui, Tingting Jiang, Ziwei Zhao, Xiong Du, Baochang Lai, Lei Xiao, Nanping Wang. Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism. Nutrients 2022; 14(9): 1756 doi: 10.3390/nu14091756
|